Search results
SpliceBio has begun the dose-expansion portion of their phase 1/2 clinical trial of SB-007, a dual adeno-associated viral vector gene therapy for Stargardt disease.
SparingVision have announced this week that they have dosed all participants in their phase 1/2 PRODYGY clinical trial for SPVN06, a gene agnostic therapy aimed at slowing disease progression in Retinitis Pigmentosa (RP).
Jenny Dewing is a postdoctoral researcher working on a Retina UK-funded project with Dr Arjuna Ratnayaka at the University of Southampton.
With Christmas parties upon us, come and join Bhavini as she shares her top tips for selecting the right make up, The best way to apply and blend, how to shop for makeup and picking the right colours.
Volunteers founded our charity in the 1970s and they continue to be at our heart.
Financial support for young people attending conference
Joe lives with retinitis pigmentosa (RP). After completing his GCSEs and A-levels, he studied History at the University of Liverpool, graduating with a 2:1. He went on to complete a Postgraduate Diploma in Sport Management at Bournemouth University, which included a semester in Cologne.
We provide funding for innovative, high quality research projects investigating the causes and potential treatments for all forms of inherited retinal disease.
Your generous support allows Retina UK to fund the work of leading scientists who are increasing understanding of inherited sight loss and moving us closer to treatments.
Including a gift to Retina UK in your Will is an incredibly special way to help our vital work continue into the future.
